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Abstract 
The synthesis of hyaluronic acid oligomers (tri- and tetrasaccharide) is described. We 
have followed a pre-glycosylation oxidation strategy. Glucuronic acid units were 
directly employed in coupling reactions with suitably protected glucosamine 
derivatives. In order to simplify the purification of synthetic intermediates, a fluorous-
assisted strategy has been also explored. Using this approach, a hyaluronic acid 
trisaccharide was prepared.    
Keywords 
Hyaluronic acid/glycosylation/fluorous tag/oligosaccharide synthesis/glucuronic 
acid/carbohydrates 
Introduction 
Hyaluronic acid is a negatively charged linear polysaccharide that belongs to the 
glycosaminoglycan family. It is constituted by the repetition of disaccharide units of D-
glucuronic acid (GlcA)-β(1→3)-N-acetyl-D-glucosamine (GlcNAc)-β(1→4). 
Hyaluronic acid is the only glycosaminoglycan that does not contain sulfate groups. 
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Despite its simple chemical structure, hyaluronic acid is involved in a wide range of 
biological processes, such as cell-migration, recognition and tumor invasion.1 The 
specific biological activities of hyaluronic acid strongly depend on the length and 
molecular weight of the carbohydrate chain.2 For example, high molecular weight 
polymers are anti-angiogenic while smaller oligosaccharide fragments induce 
angiogenesis. In this context, well-defined synthetic oligosaccharides are useful to 
elucidate the role of hyaluronic acid chains in nature. In particular, synthetic 
oligosaccharides, with defined sequence and length, are required to study, at the 
molecular level, the interactions between hyaluronic acid and certain protein receptors 
that trigger the biological functions of this natural product. These studies can potentially 
lead to the interference and control of a particular biological process. 
Several approaches have been reported for the synthesis of hyaluronic acid 
oligosaccharides.3-5 Two main strategies have been employed for the preparation of 
these molecules.6 In the pre-glycosylation oxidation strategy, glucuronic acid building 
blocks are directly used in coupling reactions. 7-14 The low reactivity of these units can 
afford low to moderate yields in the glycosylation reactions.15-17 For this reason, an 
alternative post-glycosylation oxidation approach has been also considered. In this 
second method, glucose moieties are used for the assembly of the oligosaccharide 
chain.6, 18-23 Then, glucose units are oxidized to the corresponding glucuronic acids to 
give the final hyaluronic acid molecules. The oxidation of highly elaborated 
intermediates is, however, a complex and challenging synthetic step. 
Recently, several methods have been reported to accelerate the preparation of 
hyaluronic acid oligomers, facilitating the purification of synthetic intermediates. Huang 
and coworkers6  developed a pre-activation based iterative one-pot strategy in which 
anomeric reactivity adjustment and intermediate oligosaccharide purifications are not 
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required. Using a fully automated solid-phase approach, Codée, van der Marel and 
coworkers24-25 described the synthesis of hyaluronic acid fragments up to the 
pentadecamer level.  
Here, we describe the total synthesis of one tri- and one tetrasaccharide that correspond 
to the structure of hyaluronic acid, using a stepwise strategy. Glucuronic acid building 
blocks were directly employed for the glycosylation reactions. Additionally, we have 
explored the use of a fluorous tag to facilitate the preparation of this type of compounds.           
   
Results and discussion 
For the preparation of hyaluronic acid oligosaccharides, we have followed the 
retrosynthetic analysis shown in Scheme 1. We envisaged that final molecules, such as 
tetrasaccharide 1, could be obtained from the corresponding fully protected precursors, 
such as 2, by a 3-step sequence of deprotection reactions (basic hydrolysis, selective N-
acetylation and hydrogenolysis). The oligosaccharide backbone was assembled by 
linking monosaccharide building blocks 3, 4 and 5. The levulinoyl (Lev) groups at 
position 4 of GlcA unit 3 and position 3 of glucosamine derivative 4 were chosen as 
temporary protecting groups to allow the elongation of the carbohydrate chain. The 
benzoyl and N-trichloroacetyl26 groups led to the selective formation of the 1,2-trans 
glycosidic linkages. A 4-methoxyphenyl group was used to protect the anomeric 
position of the reducing end. The trichloroacetimidate method was chosen to form the 
glycosidic linkages.27 
GlcA units 3 and 528 were prepared from commercially available 1,2;5,6-di-O-
isopropylidene-α-D-glucofuranose. Glucosamine trichloroacetimidate 4 was prepared 
from monosaccharide 610,26 as shown in Scheme 2. The anomeric acetate of 6 was 
exchanged for an anomeric silyl ether (→7). Removal of the remaining acetates 
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followed by the formation of the 4,6-benzylidene acetal and subsequent levulinoylation 
at position 3 gave monosaccharide 8 in 76% yield over three steps. The regioselective 
reductive opening of the 4,6-di-O-benzylidene acetal of compound 8 gave the 4-OH 
monosaccharide 9 in high yield. Compound 9 was then acetylated (→10), desilylated 
(→11) and activated as trichloroacetimidate (→4). 
With the required building blocks at hand, we first accomplished the preparation of 
trisaccharide 16 (Scheme 3). The glycosylation reaction between monomers 4 and 5 
gave the desired disaccharide 12 in good yield. It is important to note that the yield of 
this coupling reaction strongly depended on the protecting group distribution of the 
GlcA building block. In preliminary experiments, we also employed highly disarmed 
glucuronic acid derivatives as glycosyl acceptors to build the GlcNAc-GlcA linkage 
(see Supporting Information). However, using GlcA units that contain acyl groups at 
positions 2 and 3, the glycosylation yields were significantly lower (18-41%, see 
Supporting Information). Therefore, the use of more reactive, partially benzylated unit 5 
was crucial to increase the efficiency of the glycosidic bond formation. Disaccharide 12 
was selectively delevulinoylated to obtain glycosyl acceptor 13. Glycosylation with 
GlcA trichloroacetimidate 3 gave trisaccharide 14 in moderate yield. A considerable 
amount (18%) of unreacted acceptor 13 was also recovered from the reaction mixture. 
Treatment with H2O2/LiOH and then with NaOH hydrolyzed all the ester and amide 
groups. Selective N-acetylation afforded precursor 15 that was hydrogenated in the 
presence of Pd(OH)2 to give the fully deprotected hyaluronic acid trisaccharide 16 in 
high yield. 
Next, we carried out the synthesis of tetrasaccharide 1 (Scheme 4). Compound 14 was 
treated with hydrazine monohydrate in pyridine/acetic acid buffer to give trisaccharide 
acceptor 17. Coupling with glucosamine trichloroacetimidate 4 gave the fully protected 
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tetrasaccharide 2 in good yield. Finally, saponification followed by N-acetylation and 
hydrogenolysis afforded hyaluronic acid tetramer 1. 
The classical stepwise synthesis of oligosaccharides requires multiple chromatographic 
purifications that hamper this process. We decided to evaluate the utility of a fluorinated 
tag29-30 to facilitate the purification of the synthetic intermediates31 and, therefore, the 
preparation of the hyaluronic acid oligomers. As a first goal, we managed the fluorous-
assisted preparation of trisaccharide 15 (Scheme 5). Fluorous compounds can be easily 
separated from nonfluorinated molecules by a simple fluorous solid-phase extraction (F-
SPE) on FluoroFlash silica gel.32-33 Importantly, the reactions involving fluorous 
compounds can be monitored by standard TLC, NMR and mass spectrometry.34 
Compared to solid-phase approaches, fluorous-assisted oligosaccharide synthesis often 
consumes lower amounts of building blocks since the reactions are run in solution.35 
Our approach involved the attachment of the fluorous tag to the reducing end GlcA 
monomer through the carboxylate group (Scheme 5). Thus, starting from known diol 
19,36 oxidation with calcium hypochlorite and catalytic TEMPO followed by treatment 
with heptadecafluoroundecyl iodide in DMF at 60ºC directly gave fluorinated glycosyl 
acceptor 20. Using this strategy, the introduction of the fluorous tag did not involve 
additional synthetic steps because the analogous acceptor 5, required for the “classical” 
synthesis of oligomers 1 and 16, was also prepared from diol 19 by the same two-step 
procedure (oxidation and esterification). Fluorous acceptor 20 was then glycosylated 
with trichloroacetimidate 4, using the same reaction conditions employed for the 
preparation of comparable disaccharide 12. The crude mixture was quickly purified by 
F-SPE. The non-fluorous compounds, mainly derived from the glycosyl donor, were 
first eluted with MeOH/H2O 80:20 while the desired fluorous-tagged product was eluted 
with 100% methanol. After two glycosylation cycles, NMR and mass spectrometry 
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analysis of the fluorous fraction indicated the presence of the desired disaccharide 21 
along with a small quantity of unreacted monosaccharide acceptor 20 (6:1 ratio, 
according to the 1H-NMR data). As in solid-phase approaches, fluorous-assisted 
reactions can be driven to completion by carrying out multiple cycles. Disappointingly, 
we observed a significant loss (approximately 10%) of fluorous material after each F-
SPE purification step. Following a typical protocol for F-SPE (100 mg of reaction 
mixture purified with 3 g. of fluorous silica gel; see Experimental Section), we detected 
fluorous sample breakthrough,29 that is to say, some of the fluorous compound was 
eluted with the fluorophobic solvent (MeOH/H2O 80:20). We solved these breakthrough 
problems by using a higher amount of fluorous silica gel for the purification (up to 13 g 
of silica per 100 mg of reaction mixture). Using this modified F-SPE procedure, we did 
not detect fluorous compounds in the fluorophobic elution but we still observed a loss 
of fluorous-tagged material. To explain this result, we hypothesized that some fluorous 
product could be retained on the F-SPE column when using the high amount of silica 
required to prevent breakthrough. This experimental limitation precluded the possibility 
of performing more glycosylation cycles to completely consume acceptor 20.  
Therefore, compound 21 was directly submitted to delevulinoylation to give 
disaccharide 22. Fluorous trisaccharide 23 was obtained by coupling of 22 with GlcA 
glycosyl donor 3, after purification by F-SPE and normal silica gel chromatography. 
The overall yield for the synthesis of 23 (12%) was lower than the one obtained in the 
classical non-fluorous route (27%). This fact can be explained by the observed loss of 
material during F-SPE purifications, using our set of building blocks. Finally, the 
fluorous tag was easily removed during basic hydrolysis. Selective N-acetylation 
afforded compound 15 that can provide hyaluronic acid trisaccharide 16, as shown 
before.  
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Conclusions 
We have described a strategy for the preparation of hyaluronic acid oligosaccharides. 
Suitably protected GlcA and glucosamine monosaccharide building blocks were used 
for the assembly of the hyaluronic acid chain. Participating groups at position 2 of these 
units ensured the selective formation of the desired β glycosidic bonds. A sequence of 
deprotection reactions efficiently afforded the final tri- and tetrasacharide fragments. An 
alternative fluorous-assisted approach was also explored. F-SPE facilitated the 
purification of fluorous-tagged synthetic intermediates. We attached the fluorous tag to 
the carboxylic acid of the reducing-end GlcA moiety by an esterification reaction. Thus, 
the introduction and removal of the fluorous tail did not add any extra steps to the 
preparation of these molecules in comparison with the classical stepwise approach. The 
overall yield of the fluorous-assisted synthesis of a hyaluronic acid trisaccharide was, 
nevertheless, quite low. The moderate yield of the glycosylation involving GlcA donor 
3 and the observed loss of fluorous material after each F-SPE purification step can 
explain this result.                
 
Scheme 1. Retrosynthetic analysis for tetrasaccharide 1. 
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Scheme 2. Reagents and conditions: a) BnNH2, THF; TDSCl, imidazole, CH2Cl2, 80%; 
b) NaOMe, MeOH; PhCH(OMe)2, p-TsOH, CH3CN; LevOH, DCC, DMAP, CH2Cl2, 
76%; c) Et3SiH, CF3COOH, CH2Cl2, 85%; d) Ac2O, Py; e) (HF)n·Py, THF, 0ºC, 
quantitative (two steps, from 9); f) Cl3CCN, DBU, CH2Cl2, 70%.  
 
 
 
Scheme 3. Reagents and conditions: a) TMSOTf, CH2Cl2, 0ºC, 72%; b) NH2NH2·H2O, 
Py/AcOH, CH2Cl2, 93%; c) 3, TMSOTf, CH2Cl2, 41%; d) LiOH, H2O2, THF; NaOH, 
MeOH; Ac2O, MeOH, Et3N, 87%; e) H2, Pd(OH)2, H2O/MeOH, quantitative. 
9 
 
 
Scheme 4. Reagents and conditions: a) NH2NH2·H2O, Py/AcOH, CH2Cl2, 71%; b) 4, 
TMSOTf, CH2Cl2, 0ºC, 64%; c) LiOH, H2O2, THF; NaOH, MeOH; Ac2O, MeOH, 
Et3N, 64%; d) H2, Pd(OH)2, H2O/MeOH, quantitative. 
 
 
Scheme 5. Reagents and conditions: a) TEMPO, Ca(ClO)2, Bu4NBr, KBr, NaHCO3, 
CH2Cl2/H2O, 0ºC; C8F17-(CH2)3-I, DMF, 60ºC, 55%; b) 4, TMSOTf, CH2Cl2, 0ºC; c) 
NH2NH2·H2O, Py/AcOH, CH2Cl2; d) 3, TMSOTf, CH2Cl2, 12% (three steps, from 20); 
e) LiOH, H2O2, THF; NaOH, MeOH; Ac2O, MeOH, Et3N, 90%.    
    
 Experimental  
General procedures: Thin layer chromatography (TLC) analyses were performed on 
silica gel 60 F254 precoated on aluminium plates (Merck) and the compounds were 
detected by staining with sulfuric acid/ethanol (1:9), with cerium (IV) sulfate 
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(10 g)/phosphomolybdic acid (13 g)/sulfuric acid (60 mL) solution in water (1 L), or 
with anisaldehyde solution [anisaldehyde (25 mL) with sulfuric acid (25 mL), ethanol 
(450 mL) and acetic acid (1 mL)], followed by heating at over 200ºC. Column 
chromatography was carried out on silica gel 60 (0.2-0.5 mm, 0.2-0.063 mm or 0.040-
0.015 mm; Merck). Optical rotations were determined with a Perkin-Elmer 341 
polarimeter. 1H- and 13C-NMR spectra were acquired on Bruker DPX-300, Avance III-
400 and DRX-500 spectrometers. Unit A refers to the reducing end monosaccharide in 
the NMR data. Electrospray mass spectra (ESI MS) were carried out with an Esquire 
6000 ESI-Ion Trap from Bruker Daltonics. High resolution mass spectra (HR MS) were 
carried out by CITIUS (Universidad de Sevilla) and SIdI (Universidad Autónoma de 
Madrid). F-SPE was performed using FluoroFlash silica gel. 
General procedure for F-SPE: FluoroFlash silica gel (3 g.) was placed in a 10 mL 
plastic tube. The F-SPE column was washed with DMF (1 mL) and then preconditioned 
with MeOH/H2O 80:20 (10 mL). Next, the crude sample (100 mg) was dissolved in 
DMF (0.8 mL) and loaded on the column. The fluorophobic elution was carried out 
with 10 mL of MeOH/H2O 80:20. The fluorous compounds were then eluted using 
100% methanol (16 mL). To regenerate the F-SPE column, we washed with acetone (10 
mL).        
Dimethylthexylsilyl 3,4,6-tri-O-acetyl-2-deoxy-2-trichloroacetamido-β-D-
glucopyranoside (7): Benzylamine (0.267 mL, 2.44 mmol) was added to a solution of 6 
(1.00 g, 2.03 mmol) in THF (10 mL). After 3 h, an additional aliquot of benzylamine 
(0.267 mL, 2.44 mmol) was added. After a further 3 h, the mixture was diluted with 
CH2Cl2, and washed with 1N HCl. The organic phase was dried over Na2SO4, filtered 
and the solvent was removed under reduced pressure. The residue [TLC (3:2 
hexane/EtOAc) Rf 0.34] was dissolved in CH2Cl2 (5 mL). Imidazole (379 mg, 5.57 
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mmol) and thexyldimethylsilyl chloride (0.481 mL, 2.45 mmol) were added. After 24 h, 
the mixture was diluted with CH2Cl2 and washed with H2O. The organic layer was dried 
over MgSO4, filtered, and the solvent was removed in vacuo. Flash chromatography on 
silica gel (3:1 hexane/EtOAc) afforded 7 (964 mg, 80%). TLC (3:2 hexane/EtOAc) Rf 
0.66; []20D -6.8º (c 1.17, CHCl3); 1H-NMR (500 MHz, CDCl3):  6.89 (d, J 2,NH = 9 
Hz, 1H, NH), 5.34 (dd, 1H, H-3), 5.10 (dd, J 3,4 = J 4,5 = 9.8 Hz, 1H, H-4), 4.90 (d, J 1,2 
= 8 Hz, 1H, H-1), 4.25-4.13 (m, 2H, H-6), 4.00 (ddd, 1H, H-2), 3.76 (ddd, 1H, H-5), 
2.10-2.04 (3s, 9H, COCH3), 1.62 (m, 1H, CH(CH3)2), 0.93-0.84 (m, 12H, C(CH3)2 and 
CH(CH3)2), 0.18-0.15 (2s, 6H, Si(CH3)2); 13C-NMR (125 MHz, CDCl3):  171.1, 170.6, 
169.3, 161.8, 95.7, 92.4, 72.0, 71.8, 68.9, 62.5, 57.9, 33.9, 24.8, 20.7, 20.63, 20.60, 
20.0, 19.9, 18.53, 18.49, -1.9, -3.4; HR MS: m/z: calcd for C22H36O9NCl3SiNa: 
616.1279; found: 616.1302 [M+Na]+. 
Dimethylthexylsilyl 4,6-O-benzylidene-2-deoxy-3-O-levulinoyl-2-
trichloroacetamido-β-D-glucopyranoside (8): Compound 7 (11.5 g, 19.4 mmol) was 
dissolved in methanol (160 mL) and NaOMe (1.5 mL of a 2.17 M solution in MeOH) 
was added. After 12 h, Amberlite acidic resin was added and the mixture was stirred 
until the pH reached 7. The Amberlite resin was filtered off and the solvent was 
removed in vacuo. The residue was coevaporated with dichloromethane and toluene and 
dissolved in acetonitrile (90 mL). Benzaldehyde dimethyl acetal (3.5 mL, 23.2 mmol) 
and p-toluenesulfonic acid (367 mg, 1.9 mmol) were added. After stirring at room 
temperature for 3 h, EtOAc was added and the mixture was extracted with saturated 
NaHCO3 solution. The organic phase was dried over Na2SO4, filtered and concentrated 
in vacuo. The residue [TLC (3:2 hexane/AcOEt) Rf 0.73] was dissolved in CH2Cl2 (113 
mL) and levulinic acid (9.9 mL, 97 mmol), 1,3-dicyclohexylcarbodiimide (6.0 g, 29 
mmol) and DMAP (500 mg) were added. After 3 h, the mixture was diluted with 
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CH2Cl2 and washed with saturated NaHCO3 solution. The organic phase was dried over 
Na2SO4, filtered and concentrated in vacuo. The residue was purified by flash 
chromatography on silica gel (3:1 hexane/EtOAc) to give 8 (9.7 g, 76%). TLC (3:1 
hexane/EtOAc) Rf 0.5; []20D -47.2º (c 3.17, CHCl3); 1H-NMR (300 MHz, CDCl3):  
7.43-7.26 (m, 6H, Ph, NH), 5.40 (m, 2H, H-3, PhCHO), 4.70 (d, J 1,2 = 7.8 Hz, 1H, H-
1), 3.94 (ddd, 1H, H-2), 3.86 (dd, J 5,6a = 5.0 Hz, J 6a,6b = 10.4 Hz, 1H, H-6a), 3.61 (m, 
2H, H-4, H-6b), 3.30 (ddd, 1H, H-5), 2.68-2.48 (m, 4H, OCO(CH2)2), 2.06 (s, 3H, 
COCH3), 1.51 (m, 1H, CH(CH3)2), 0.80-0.73 (m, 12H, C(CH3)2 and CH(CH3)2), 0.00 
(2s, 6H, Si(CH3)2); 13C-NMR (75 MHz, CDCl3):  205.8, 173.3, 162.2, 137.2-126.1 
(Ph), 101.1, 96.2, 92.7, 79.0, 71.9, 68.5, 66.2, 58.4, 38.1, 34.0, 29.9, 28.4, 24.8, 20.2, 
20.0, 18.7, 18.6, -1.7, -3.2; HR MS: m/z: calcd for C28H40O8NCl3SiNa: 674.1486; 
found: 674.1448 [M+Na]+. 
Dimethylthexylsilyl 6-O-benzyl-2-deoxy-3-O-levulinoyl-2-trichloroacetamido-β-D-
glucopyranoside (9): The starting material 8 (3 g, 4.6 mmol) was co-evaporated with 
toluene, dissolved in dry CH2Cl2 (30 mL) and further dried by stirring over activated 4Å 
molecular sieves (3 g) for 30 min. Triethylsilane (8.8 mL, 55.2 mmol) was added at 
room temperature, followed by the slow addition of trifluoroacetic acid (4.5 mL, 60.7 
mmol). After 10 min the reaction was filtered and diluted with CH2Cl2. The reaction 
mixture was washed with saturated NaHCO3 and water, dried over Mg2SO4, filtered and 
concentrated. The residue was purified by column cromatography (2:1 → 1:1 hexane: 
EtOAc) to afford 9 (2.55 g, 85%). TLC (2:1 hexane/EtOAc) Rf 0.24; [] 20D  -22.9º (c 1, 
CHCl3); 1H-NMR (300 MHz, CDCl3):  7.39-7.27 (m, 5H, Ar), 6.78 (br d, 1H, J NH,2 = 
9.3 Hz, NH), 5.13 (dd, 1H, J 2,3 = J 3,4 = 10.6 Hz, H-3), 4.81 (d, 1H, J 1,2 = 7.9 Hz, H-1), 
4.60 (m, 2H, CH2(Bn)), 3.92 (m, 1H, H-2), 3.81-3.75 (m, 3H, H-4, H-6a and H-6b),  
3.58 (m, 1H, H-5), 2.81-2.44 (m, 4H, OCO(CH2)2), 2.17 (s, 3H, COCH3), 1.60 (m, 1H, 
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CH(CH3)2), 0.86-0.82 (m, 12H, C(CH3)2 and CH(CH3)2), 0.18-0.13 (2s, 6H, Si(CH3)2); 
13C-NMR (75MHz, CDCl3):  207.8, 173.4, 162.0 (C=O), 138.1-127.7 (Ar-CH and Ar-
C), 95.8 (C-1), 92.7 (CCl3), 75.7, 74.5 (C-3 and C-5), 73.7 (CH2(Bn)), 70.2, 69.9 (C-4 
and C-6), 57.6 (C-2), 38.4 (OCO(CH2)2), 34.0 (CH(CH3)2), 29.9 (COCH3), 28.4 
(OCO(CH2)2), 24.8, 20.1, 20.0, 18.7, 18.6 (CH(CH3)2), C(CH3)2) and C(CH3)2)), -1.7, -
3.2 (Si(CH3)2)); HR MS: m/z: calcd for C28H42Cl3NO8SiNa: 676.1643; found: 676.1675 
[M+Na]+.  
O-(4-O-acetyl-6-O-benzyl-2-deoxy-3-O-levulinoyl-2-trichloroacetamido-α,β-D-
glucopyranosyl) trichloroacetimidate (4): Ac2O (6 mL) was added to a solution of 9 
(1.2 g, 1.83 mmol) in pyridine (12 mL). After stirring for 10 min at 0°C and 1 hour at 
room temperature, the mixture was diluted with EtOAc and washed with 1N HCl, 
saturated NaHCO3 solution and H2O. The organic layer was dried over Na2SO4, filtered 
and concentrated in vacuo to give 10. TLC (3:2 hexane/EtOAc) Rf 0.53; 1H-NMR (300 
MHz, CDCl3):  7.26 (m, 5H, Ar), 6.74 (br d, 1H, J NH,2 = 9.0 Hz, NH), 5.24 (t, 1H, H-
3), 5.04 (t, 1H, J 3,4 = J 4,5 = 9.7 Hz, H-4), 4.84 (d, 1H, J 1,2 = 7.9 Hz, H-1), 4.48 (2d, 2H, 
CH2(Bn)), 3.85 (m, 1H, H-2), 3.64 (m, 1H, H-5), 3.50 (m, 2H, H-6a and H-6b), 2.66-
2.39 (m, 4H, OCO(CH2)2), 2.09 (s, 3H, COCH3), 1.95 (COCH3), 1.56 (m, 1H, 
CH(CH3)2), 0.79 (m, 12H, C(CH3)2 and CH(CH3)2), 0.14,0.09 (2s, 6H, Si(CH3)2) ppm.  
Compound 10 (1.83 mmol) was dissolved in dry THF (25 mL) and (HF)n.Py complex 
(5.2 mL) was added at 0ºC. After stirring for 5 days at 0ºC, the reaction mixture was 
diluted with CH2Cl2 and extracted with H2O and saturated NaHCO3 solution. The 
organic layer was dried over Na2SO4, filtered, and the solvents were removed in vacuo 
to yield 11 (1.0 g, quantitative, 2 steps, from 9). TLC (1:1 hexane/EtOAc) Rf α 0.50, Rf 
β 0.29; Data for the α anomer: 1H-NMR (300 MHz, CDCl3):  7.26 (m, 5H, Ar), 6.92 
(br d, 1H, J NH,2 = 9.0 Hz, NH), 5.36-5.27 (m, 2H, H-1 and H-3), 5.03 (pt, 1H, H-4), 
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4.67 (2d, 2H, CH2(Bn)), 4.13 (m, 2H, H-2 and H-5), 3.47 (m, 2H, H-6a and H-6b), 2.72-
2.32 (m, 4H, OCO(CH2)2), 2.08 (s, 3H, COCH3), 1.95 (COCH3) ppm; ESI-MS: m/z: 
calcd for C22H26Cl3NNaO9: 576.1; found: 576.1 [M+Na]+.  
Compound 11 (527 mg, 0.95 mmol) was dissolved in dry CH2Cl2 (10 mL) and Cl3CCN 
(0.95 mL, 9.5 mmol) and DBU (1.4 μL, 9.5 μmol) were added. After stirring at room 
temperature for 1 h, the mixture was concentrated in vacuo. Flash chromatography on 
silica gel (hexane/EtOAc 3:1 + 1% Et3N) afforded 4 (463 mg, 70%) as an α/β mixture. 
TLC (2:1 hexane/EtOAc) Rf 0.45; Data for the α anomer: 1H-NMR (300 MHz, CDCl3): 
 8.74 (s, 1H, NH), 7.26 (m, 5H, Ar), 6.97 (br d, 1H, J NH,2 = 8.2 Hz, NH), 6.46 (d, 1H, J 
1,2 = 3.5 Hz, H-1), 5.44-5.32 (m, 2H, H-3 and H-4), 4.48 (2d, 2H, CH2(Bn)), 4.36 (m, 
1H, H-2), 4.07 (m, 1H, H-5), 3.53 (m, 2H, H-6a and H-6b),  2.78-2.36 (m, 4H, 
OCO(CH2)2), 2.11 (s, 3H, COCH3), 1.98 (s, 3H, COCH3) ppm; HR MS: m/z: calcd for 
C24H26Cl6N2NaO9: 718.9667; found: 718.9669 [M+Na]+. 
Benzyl [4-Methoxyphenyl 2-O-benzoyl-3-O-benzyl-4-O-(4-O-acetyl-6-O-benzyl-2-
deoxy-3-O-levulinoyl-2-trichloroacetamido-β-D-glucopyranosyl)-β-D-
glucopyranoside]uronate (12): Donor 4 (3.73 g, 5.34 mmol) and acceptor 5 (2.4 g, 4.1 
mmol) were coevaporated with toluene, dried under vacuum, and dissolved in dry 
CH2Cl2 (90 mL) in the presence of freshly activated 4Å molecular sieves. After stirring 
for 10 min, TMSOTf (199 µL, 1.1 mmol) was added under an argon atmosphere at 0 ºC. 
After stirring for 10 min at 0 ºC, the reaction mixture was neutralized with Et3N, 
filtered, and concentrated to dryness. The residue was purified by column 
chromatography (toluene/acetone 14:1) to afford 12 (3.31 g, 72%). TLC (hexane/EtOAc 
3:2) Rf 0.38; [α] 20D  +14.1º (c 1.0, CHCl3); 1H-NMR (500 MHz, CDCl3):  7.93 (m, 2H, 
Ar), 7.56 (m, 1H, Ar), 7.45-7.37 (m, 6H, Ar), 7.33 (m, 2H, Ar), 7.26 (m, 4H, Ar), 7.16 
(m, 2H, Ar), 7.05 (m, 3H, Ar),  6.87 (m, 3H, NH and Ar), 6.69 (m, 2H, Ar), 5.44 (dd, 
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1H, J1,2 = 7.1 Hz, J2,3 = 9.0 Hz, H-2A), 5.27, 5.10 (2d, 2H, Jgem = 12.0 Hz, CH2(Bn)), 
5.06 (t, 1H, J3,4 = J4,5 = 9.5 Hz,  H-4B), 4.99 (d, 1H, J1,2 = 7.1 Hz, H-1A), 4.93 (t, 1H, 
H-3B), 4.90, 4.63 (2d, 2H, Jgem = 11.7 Hz, CH2(Bn)), 4.41 (d, 1H, J1,2 = 8.4 Hz, H-1B), 
4.32 (2d, 2H, CH2(Bn)), 4.21 (t, 1H, J3,4 = J4,5 = 9.1 Hz,  H-4A), 4.06-4.00 (m, 2H, H-
5A and H-2B), 3.82 (pt, 1H, H-3A), 3.72 (s, 3H, OCH3), 3.47 (m, 1H, H-6B), 3.33-3.26 
(m, 2H, H-5B and H-6B), 2.71-2.42 (m, 4H, OCO(CH2)2), 2.15 (s, 3H, COCH3), 1.97 
(s, 3H, COCH3) ppm; 13C-NMR (125 MHz, CDCl3):  206.1 (CO(Lev)), 172.3, 169.8, 
168.9, 165.1, 162.1 (CO), 155.8, 151.0 (Ar-C), 138.1-114.5 (Ar-C, Ar-CH), 101.0 (C-
1A), 100.1 (C-1B), 92.5 (CCl3), 79.6 (C-3A), 78.1 (C-4A), 75.3 (CH2(Bn)), 74.5 (C-
5A), 73.7 (C-5B), 73.6 (CH2(Bn)), 73.0 (C-2A), 72.8 (C-3B), 69.1 (C-6B), 68.8 (C-4B), 
68.0 (CH2(Bn)), 56.0 (C-2B), 55.7 (OCH3), 37.8 (OCO(CH2)2), 29.7 (COCH3), 28.1 
(OCO(CH2)2), 20.8 (COCH3); HR MS: m/z: calcd for C56H56NO17NaCl3: 1142.2512; 
found: 1142.2543 [M+Na]+. 
Benzyl [4-Methoxyphenyl 2-O-benzoyl-3-O-benzyl-4-O-(4-O-acetyl-6-O-benzyl-2-
deoxy-2-trichloroacetamido-β-D-glucopyranosyl)-β-D-glucopyranoside]uronate 
(13): Compound 12 (200 mg, 0.18 mmol) was dissolved in CH2Cl2 (2.5 mL) and 
hydrazine monohydrate (340 µL of a 1 M solution in Py/AcOH 3:2) was added. After 
stirring at room temperature for 2 h, the reaction mixture was quenched with acetone 
(0.1 mL), diluted with EtOAc and washed with 1N HCl (aq.), saturated NaHCO3 sol., 
and H2O. The organic layer was dried over MgSO4, filtered and concentrated in vacuo. 
The residue was purified by column chromatography (toluene/acetone 7:1) to yield 13 
(170 mg, 93%). TLC (3:2 hexane/EtOAc) Rf 0.30; [α] 20D  +16.6 º (c 1.0, CHCl3); 1H-
NMR (500 MHz, CDCl3):  7.94 (m, 2H, Ar), 7.57 (m, 1H, Ar), 7.43-7.37 (m, 7H, Ar 
and NH), 7.33 (m, 2H, Ar), 7.26 (m, 4H, Ar), 7.15 (m, 2H, Ar), 7.05 (m, 3H, Ar),  6.88 
(m, 2H, Ar), 6.70 (m, 2H, Ar), 5.45 (dd, 1H, J1,2 = 7.2 Hz, J2,3 = 9.1 Hz, H-2A), 5.28, 
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5.15 (2d, 2H, Jgem = 12.2 Hz, CH2(Bn)), 5.01 (d, 1H, J 1,2 = 7.2 Hz, H-1A), 4.93-4.89 
(m, 2H, H-4B and CH2(Bn)), 4.62 (d, 1H, Jgem = 11.8 Hz, CH2(Bn)), 4.38 (d, 1H, J1,2 = 
8.3 Hz, H-1B), 4.31 (s, 2H, CH2(Bn)), 4.17 (pt, 1H, H-4A), 4.08 (d, 1H, J4,5 = 9.5 Hz, 
H-5A), 3.85-3.80 (m, 2H, H-3A and H-2B), 3.73 (s, 3H, OCH3), 3.50-3.46 (m, 2H, H-
3B and H-6B), 3.33 (m, 1H, H-6B), 3.30 (m, 1H, H-5B), 2.00 (s, 3H, COCH3) ppm; 
13C-NMR (125 MHz, CDCl3):  170.7, 169.3, 165.1, 163.6 (CO), 155.8, 151.0 (Ar-C), 
138.0-114.5 (Ar-C, Ar-CH), 100.9 (C-1A), 99.7 (C-1B), 92.6 (CCl3), 79.7 (C-3A), 78.1 
(C-4A), 75.2 (CH2(Bn)), 74.4 (C-5A), 74.3 (C-3B), 73.7 (C-5B), 73.6 (CH2(Bn)), 72.9 
(C-2A), 72.2 (C-4B), 69.1 (C-6B), 68.0 (CH2(Bn)), 58.7 (C-2B), 55.6 (OCH3), 20.9 
(COCH3); HR MS: m/z: calcd for C51H50NO15NaCl3: 1044.2144; found: 1044.2161 
[M+Na]+. 
4-Methoxyphenyl O-(Benzyl 2-O-benzoyl-3-O-benzyl-4-O-levulinoyl-β-D-
glucopyranosyluronate)-(1→3)-O-(4-O-acetyl-6-O-benzyl-2-deoxy-2-
trichloroacetamido-β-D-glucopyranosyl)-(1→4)-benzyl 2-O-benzoyl-3-O-benzyl-β-
D-glucopyranosiduronate (14): Donor 3 (275 mg, 0.38 mmol) and aceptor 13 (300 mg, 
0.29 mmol) were coevaporated with toluene, dried under vacuum, and dissolved in dry 
CH2Cl2 (4 mL) in the presence of activated 4Å molecular sieves. The reaction mixture 
was stirred, under an argon atmosphere, for 10 min and TMSOTf (14 µL, 76 µmol) was 
then added. After stirring for 15 min, the reaction mixture was neutralized with Et3N, 
filtered, and concentrated to dryness. The residue was purified by column 
chromatography (toluene/acetone 10:1) to yield 14 (192 mg, 41%) and starting acceptor 
(56 mg, 18%). TLC (toluene/acetone 7:1) Rf 0.28; [α] 20D  +15.6º (c 1.0, CHCl3); 1H-
NMR (500 MHz, CDCl3):  8.04 (m, 2H, Ar), 7.93 (m, 2H, Ar), 7.54 (m, 2H, Ar), 7.44-
7.24 (m, 17H, Ar), 7.14-7.02 (m, 12H, Ar), 6.90 (br d, 1H, J2,NH = 7.8 Hz, NH), 6.86 (m, 
2H, Ar), 6.68 (m, 2H, Ar), 5.41 (dd, 1H, J1,2 = 6.9 Hz, J2,3 = 8.4 Hz, H-2A), 5.28-5-22 
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(m, 2H, H-2C and H-4C), 5.20-5.08 (m, 4H, 2CH2(Bn)), 5.00 (d, 1H, J1,2 = 6.8 Hz, H-
1A), 4.90 (t, 1H, J3,4 =  J4,5 = 9.4 Hz,  H-4B), 4.84-4.80 (m, 2H, H-1B and H-1C), 4.75 
(d, 1H, Jgem = 11.6 Hz, CH2(Bn)), 4.59-4.53 (m, 3H, CH2(Bn)), 4.36-4.26 (m, 3H, H-4A 
and CH2(Bn)), 4.18 (pt, 1H, H-3B), 4.02 (d, 1H, J4,5 = 8.8 Hz, H-5A), 4.00 (d, 1H, J4,5 = 
10.0 Hz, H-5C), 3.80-3.73 (m, 2H, H-3A and H-3C), 3.72 (s, 3H, OCH3), 3.55 (m, 1H, 
H-2B), 3.44 (dd, 1H, J5,6b= 3.0 Hz, J6a,6b= 10.7 Hz, H-6bB), 3.37 (m, 1H, H-5B), 3.26 
(dd, 1H, J5,6a= 5.4 Hz, J6a,6b= 10.7 Hz, H-6aB), 2.55-2.19 (m, 4H, OCO(CH2)2), 2.10 (s, 
3H, COCH3), 1.78 (s, 3H, COCH3) ppm; 13C-NMR (125 MHz, CDCl3):  
206.0(CO(Lev)), 171.4 (CO(Lev)), 169.9, 168.5, 167.1, 165.2, 164.8, 161.5 (CO), 
155.7, 151.1 (Ar-C), 138.1-114.5 (Ar-C, Ar-CH), 100.9 (C-1A), 99.1 (C-1C), 98.6 (C-
1B), 92.8 (CCl3), 79.4 (C-3A), 79.1 (C-3C), 76.6 (C-4A), 75.9 (C-3B), 74.8, 74.6 
(CH2(Bn) and C-5A), 74.1, 73.9, 73.6 (2CH2(Bn) and C-5B), 73.1 (C-2A), 72.8, 72.7 
(C-2C and C-5C), 71.3 (C-4C), 69.3 (C-6B), 68.7 ((C-4B), 68.1 (CH2(Bn)), 67.8 
(CH2(Bn)), 58.5 (C-2B), 55.7 (OCH3), 37.7 (OCO(CH2)2), 29.9 (COCH3), 27.8 
(OCO(CH2)2),  20.6 (COCH3); HR MS: m/z: calcd for C83H80NO24NaCl3: 1602.4034; 
found: 1602.4025 [M+Na]+. 
4-Methoxyphenyl O-(β-D-glucopyranosyluronic acid)-(1→3)-O-(2-acetamido-2-
deoxy-β-D-glucopyranosyl)-(1→4)-β-D-glucopyranosiduronic acid (16): H2O2 (30%, 
0.31 mL) and a solution of LiOH (0.7 M, 0.19 mL) were added at -5 ºC to a solution of 
14 (11.6 mg, 7.3 µmol) in THF (0.83 mL). After stirring for 24 h at room temperature, 
MeOH (0.83 mL) and a solution of NaOH (4 M, 0.18 mL) were added. After stirring for 
72 h at room temperature, the reaction was neutralized with Amberlite IR-120, filtered 
and concentrated. The residue was dissolved in MeOH (1 mL) and Et3N (4 µL) and 
Ac2O (5µL) were added at 0 ºC. After stirring for 1 h at room temperature, the reaction 
was coevaporated with toluene and methanol. The residue was dissolved in MeOH (1 
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mL) and NaOH (0.25 M, 0.2 mL) was added. After stirring for 12 h the reaction was 
neutralized with Amberlite IR-120 and filtered. Et3N (0.3 mL) was added and the 
reaction mixture was purified by Sephadex LH-20 chromatography (CH2Cl2-MeOH 
1:1). The residue was converted into the sodium salt by elution from a column of 
Dowex 50WX4-Na+ with MeOH-H2O 9:1 to give 15 (6.5 mg, 87%). 
Alternative synthesis of intermediate 15 from fluorous-tagged 23: H2O2 (30%, 0.3 mL) 
and a solution of LiOH (0.7 M, 0.19 mL) were added at -5 ºC to a solution of 23 (15 
mg, 7.7 µmol) in THF (1.2 mL). After stirring for 24 h at room temperature, MeOH (1 
mL) and a solution of NaOH (4 M, 385 µL) were added. After stirring for 4 days at 
room temperature, the reaction was neutralized with Amberlite IR-120, filtered and 
concentrated. The residue was dissolved in MeOH (2.1 mL) and Et3N (14 µL) and Ac2O 
(14 µL) were added at 0 ºC. After stirring for 1 h at room temperature, the reaction was 
coevaporated with toluene and methanol. Et3N (0.3 mL) was added and the reaction 
mixture was purified by Sephadex LH-20 chromatography (CH2Cl2-MeOH 1:1). The 
residue was converted into the sodium salt by elution from a column of Dowex 50WX4-
Na+ with MeOH-H2O 4:1 to give 15 (6.9 mg, 90%). TLC (EtOAc:MeOH:H2O 20:5:3) 
Rf 0.35; 1H-NMR (500 MHz, MeOD):  7.44 (m, 4H, Ar), 7.32-7.17 (m, 11H, Ar), 7.03 
(m, 2H, Ar), 6.81 (m, 2H, Ar), 5.07 (d, Jgem = 11.2 Hz, 1H, CH2(Bn)), 4.89 (m, 2H, 
CH2(Bn)), 4.81 (d, J1,2 = 7.8 Hz, 1H, H-1A), 4.76 (d, Jgem = 11.2 Hz, 1H, CH2(Bn)), 
4.69 (d, J1,2 = 8.5 Hz, 1H, H-1B), 4.52 (d, Jgem = 11.9 Hz, 1H, CH2(Bn)), 4.43 (d, J1,2 = 
7.4 Hz, 1H, H-1C), 4.36 (d, Jgem = 11.9 Hz, 1H, CH2(Bn)), 4.05 (pt, 1H, H-4A), 3.89 
(pt, 1H, H-2B), 3.85 (m, 1H, H-6B), 3.80 (d, J4,5 = 9.7 Hz, 1H, H-5A), 3.74 (s, 3H, 
OCH3), 3.69-3.52 (m, 6H, H-2A, H-3B, H-6B, H-5C, H-4C and H-3A), 3.48 (m, 2H, H-
5B and H-4B), 3.44-3-38 (m, 2H, H-2C and H-3C), 2.07 (s, 3H, NHCOCH3) ppm; 
13C-NMR (125 MHz, MeOD) (selected data from HSQC experiment):  151.5-115.0 
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(Ar), 104.6 (C-1C), 102.9 (C-1A), 100.8 (C-1B), 85.1 (C-2C or C-3C), 84.8 (C-3B or 
C-5C), 83.7 (C-3A), 79.7 (C-4A), 78.0 (C-5A), 77.0 (C-4B or C-5B), 75.1 (CH2(Bn)), 
75.0 (CH2(Bn)), 74.9 (C-3B or C-5C), 74.2 (CH2(Bn)), 74.2 (C-2C or C-3C), 73.6 (C-
2A), 73.0 (C-4C), 70.7 (C-4B or C-5B), 70.5 (C-6B), 56.2 (C-2B), 55.7 (OCH3), 23.7 
(NHCOCH3); HR MS: m/z: calcd for C48H53NO19: 473.6611; found: 473.6622 [M]2-.  
A solution of 15 (6.5 mg, 6.5 µmol, as sodium salt) in H2O/MeOH (3.6 mL/0.4 mL) was 
hydrogenated at 1 bar pressure in the presence of Pd(OH)2 (5 mg). After 24 h, the 
suspension was filtered over Celite and concentrated. The residue was purified by 
Sephadex G-10 chromatography (H2O-MeOH 9:1) to give 16 after lyophilisation (4.6 
mg, quantitative). 1H-NMR (500 MHz, D2O):  7.10 (m, 2H, Ar), 6.98 (m, 2H, Ar), 
5.00 (d, 1H, J1,2 = 7.8 Hz, H-1A), 4.60 (d, 1H, J1,2 = 8.5 Hz, H-1B), 4.47 (d, 1H, J1,2 = 
7.9 Hz, H-1C), 3.94 (dd, 1H, J5,6a = 2.0 Hz, J6a,6b = 12.7 Hz, H-6B), 3.89-3.78 (m, 7H, 
H-2B, H-4A, H-5A, OCH3 and H-6B), 3.75-3.68 (m, 3H, H-3B, H-5C and H-3A), 3.61 
(dd, J1,2 = 7.9 Hz, J2,3 = 9.5 Hz, 1H, H-2A), 3.56 (pt, 1H, H-4B), 3.50 (m, 3H, H-3C, H-
4C and H-5B), 3.33 (m, 1H, H-2C), 2.04 (s, 3H, NHCOCH3) ppm; 13C-NMR (125 
MHz, D2O) (selected data from HSQC experiment):  118.1, 115.0 (Ar), 102.9 (C-1C), 
101.3 (C-1A), 100.5 (C-1B),82.9 (C-3B or C5C), 79.8 (C-4A or C-5A), 76.6 (C-4A or 
C-5A), 75.6 (C-3B or C5C), 75.3 (C-5B or C-3C or C-4C), 73.6 (C-3A), 72.7 (C-2C), 
72.5 (C-2A), 71.6 (C-5B or C-3C or C-4C), 68.5 (C-4B), 60.5 (C-6B), 55.7 (OCH3),  
54.2 (C-2B), 22.4 (NHCOCH3); HR MS: m/z: calcd for C27H35NO19: 338.5907; found: 
338.5904 [M]2-. 
4-Methoxyphenyl O-(benzyl 2-O-benzoyl-3-O-benzyl-β-D-glucopyranosyluronate)-
(1→3)-O-(4-O-acetyl-6-O-benzyl-2-deoxy-2-trichloroacetamido-β-D-
glucopyranosyl)-(1→4)-benzyl 2-O-benzoyl-3-O-benzyl-β-D-glucopyranosiduronate 
(17): Compound 14 (124 mg, 0.08 mmol) was dissolved in CH2Cl2 (2.0 mL) and 
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hydrazine monohydrate (152 µL of a 1 M solution in Py/AcOH 3:2) was added. After 
stirring at room temperature for 2 h, the reaction mixture was quenched with acetone 
(0.1 mL). The mixture was diluted with EtOAc and washed with 1N HCl (aq.), 
saturated NaHCO3 sol., and H2O. The organic layer was dried (MgSO4), filtered and 
concentrated in vacuo. The residue was purified by column chromatography 
(toluene/acetone 7:1) to yield 17 (82 mg, 71%). TLC (toluene/acetone 6:1) Rf 0.28; 
[α] 20D  +6.9º (c 1.0, CHCl3); 1H-NMR (500 MHz, CDCl3):  8.04 (m, 2H, Ar), 7.94 (m, 
2H, Ar), 7.56 (m, 2H, Ar), 7.44-7.24 (m, 17H, Ar), 7.19-7.01 (m, 12H, Ar), 6.86 (m, 
2H, Ar), 6.81 (d, 1H, J2,NH = 8.0 Hz, NH), 6.68 (m, 2H, Ar), 5.41 (dd, 1H, J1,2 = 7.0 Hz, 
J2,3 = 8.4 Hz, H-2A), 5.27 (2d, 2H, CH2(Bn)), 5.17 (m, 2H, H-2C and CH2(Bn)), 5.10 
(d, 1H, Jgem = 12.1 Hz, CH2(Bn)), 5.00 (d, 1H, J1,2 = 6.9 Hz, H-1A), 4.88 (pt, 1H, H-
4B), 4.81 (d, 1H, H-1B), 4.77-4.74 (m, 2H, H-1C and CH2(Bn)), 4.68 (s, 2H, CH2(Bn)), 
4.53 (d, 1H, Jgem = 11.7 Hz, CH2(Bn)), 4.36-4.26 (m, 3H, H-4A and CH2(Bn)), 4.13 (pt, 
1H, H-3B), 4.03-4.00 (m, 2H, H-5A and H-4C), 3.92 (d, 1H, J4,5 = 9.9 Hz, H-5C), 3.76 
(pt, 1H, H-3A), 3.72 (s, 3H, OCH3), 3.64-3.55 (m, 2H, H-2B and H-3C), 3.45 (dd, 1H, 
J5,6b= 3.0 Hz, J6a,6b= 10.6 Hz, H-6bB), 3.40 (m, 1H, H-5B), 3.27 (dd, 1H, J5,6a= 5.2 Hz, 
J6a,6b= 10.6 Hz, H-6aB), 1.75 (s, 3H, COCH3) ppm; 13C-NMR (125 MHz, CDCl3):  
169.7, 168.6, 168.4, 165.2, 165.1, 161.4 (CO),  155.7, 151.0 (Ar-C), 138.1-114.5 (Ar-C, 
Ar-CH), 100.9 (C-1A), 99.8 (C-1C), 98.7 (C-1B), 92.8 (CCl3), 80.9 (C-3C), 79.4 (C-
3A), 76.7 (C-4A), 76.2 (C-3B), 74.8, 74.7, 74.7, 74.6 (2CH2(Bn), C-5C, C-5A), 73.9 
(C-5B), 73.6 (CH2(Bn)), 73.1 (C-2A), 72.9 (C-2C), 72.1 (C-4C), 69.4 (C-6B), 69.0 (C-
4B), 67.8 (2 CH2(Bn)), 58.3 (C-2B), 55.7 (OCH3), 20.6 (COCH3); HR MS: m/z: calcd 
for C78H74NO22NaCl3: 1504.3666; found: 1504.3644 [M+Na]+. 
4-Methoxyphenyl O-(4-O-acetyl-6-O-benzyl-2-deoxy-3-O-levulinoyl-2-
trichloroacetamido-β-D-glucopyranosyl)-(1→4)-O-(Benzyl 2-O-benzoyl-3-O-
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benzyl-β-D-glucopyranosyluronate)-(1→3)-O-(4-O-acetyl-6-O-benzyl-2-deoxy-2-
trichloroacetamido-β-D-glucopyranosyl)-(1→4)-benzyl 2-O-benzoyl-3-O-benzyl-β-
D-glucopyranosyluronate (2): Donor 4 (56 mg, 0.08 mmol) and aceptor 17 (80 mg, 
0.05 mmol) were coevaporated with toluene, dried under vucuum, and dissolved in dry 
CH2Cl2 (2 mL) in the presence of freshly activated 4Å molecular sieves. After stirring 
for 10 min at 0 ºC, TMSOTf (100 µL of a 0.16 M solution in dry CH2Cl2) was added 
under an argon atmosphere. After stirring for 10 min at 0 ºC, the reaction mixture was 
neutralized with Et3N, filtered, and concentrated to dryness. The residue was purified by 
column chromatography (toluene/EtOAc 4:1) to afford 2 (69 mg, 64%). TLC (4:1 
toluene/EtOAc) Rf 0.30; [α] 20D  +6.5º (c 1.0, CHCl3); 1H-NMR (500 MHz, CDCl3):  
7.94 (m, 4H, Ar), 7.54 (m, 2H, Ar), 7.48-7.22 (m, 25H, Ar), 7.12 (m, 2H, Ar), 7.08-7.02 
(m, 7H, Ar), 6.85 (m, 2H, Ar), 6.83 (br d, 1H, JNH,2 = 9.2 Hz, NHD), 6.74 (br d, 1H, 
JNH,2 = 8.1 Hz, NHB), 6.67 (m, 2H, Ar), 5.42-5.37 (m, 2H, H-2A and CH2(Bn)), 5.16-
5.08 (m, 4H, H-2C and CH2(Bn)), 5.02-4.98 (m, 2H, H-1A and H-4D), 4.89-4.82 (m, 
3H, H-1B, H-4B and H-3D), 4.79-4.72 (m, 3H, H-1C and CH2(Bn)), 4.54 (d, 1H, Jgem = 
11.5 Hz, CH2(Bn)), 4-35-4.25 (m, 5H, H-4A and 2CH2(Bn)), 4.18 (d, 1H, J1,2 = 8.5 Hz, 
H-1D), 4.10-4.03 (m, 2H, H-3B and H-4C), 4.01 (d, 1H, J4,5 = 8.9 Hz, H-5A), 3.98-3.92 
(m, 2H, H-2D and H-5C), 3.76 (t, 1H, J2,3 = J3,4 = 8.5 Hz, H-3A), 3.71 (s, 3H, OCH3), 
3.64-3.57 (m, 2H, H-3C and H-2B), 3.46-3.38 (m, H-5B and 2H6), 3.26 (m, 2H, 2H6), 
3.15 (m, 1H, H-5D), 2-76-2.42 (m, 4H, OCO(CH2)2), 2.15 (s, 3H, COCH3), 1.98 (s, 3H, 
COCH3), 1.78 (s, 3H, COCH3)  ppm; 13C-NMR (125 MHz, CDCl3):  206.2 (CO(Lev)), 
172.3 (CO(Lev)), 169.8, 169.5, 168.7, 168.5, 165.2, 165.1, 162.3, 161.6 (CO), 155.7, 
151.0 (Ar-C), 138.1-114.5 (Ar-C and Ar-CH), 100.9 (C-1A), 99.9, 99.8 (C-1C and C-
1D), 99.0 (C-1B), 92.7, 92.5 (2CCl3), 79.5 (C-3A), 79.4 (C-3C), 77.8 (C-4C), 77.4, 76.4 
(C-3B and C-4A), 75.0, 74.7 (x3) (2CH2(Bn), C-5A and C-5C), 73.9, 73.7, 73.6 (x2) 
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(C-5D, C-5B and 2 CH2(Bn)), 73.1 (C-2A), 72.8 (C-2C), 72.6 (C-3D), 69.6, 69.4, 69.0, 
68.8 (C-6B, C-6D, C-4B and C4D), 68.0 (CH2(Bn)), 67.8 (CH2(Bn)), 58.1 (C-2B), 56.0 
(C-2D), 55.7 (OCH3), 37.8 (OCO(CH2)2), 29.8 (COCH3), 28.1 (OCO(CH2)2), 20.8, 20.6 
(COCH3); HR MS: m/z: calcd for C100H106N4O30Cl6: 1028.2501; found: 1028.2558 
[M+2NH4]2+. 
4-Methoxyphenyl O-(2-acetamido-2-deoxy-β-D-glucopyranosyl)-(1→4)-O-(β-D-
glucopyranosyluronic acid)-(1→3)-O-(2-acetamido-2-deoxy-β-D-glucopyranosyl)-
(1→4)-β-D-glucopyranosiduronic acid (1): H2O2 (30%, 0.42 mL) and a solution of 
LiOH (0.7 M, 0.25 mL) were added at -5 ºC  to a solution of 2 (20 mg, 10 µmol) in THF 
(1 mL). After stirring for 24 h at room temperature, MeOH (1 mL) and a solution of 
NaOH (4 M, 0.25 mL) were added. After stirring for 5 days at room temperature, the 
reaction  was neutralized with Amberlite IR-120, filtered and concentrated. The residue 
was dissolved in 1 mL of MeOH and Et3N (5 µL) and Ac2O (6 µL) were added at 0 ºC. 
After stirring for 2 h at room temperature, the reaction was coevaporated with toluene 
and methanol. The residue was dissolved in MeOH (1 mL) and NaOH (0.3 M, 0.2 mL) 
was added. After stirring for 12 h the reaction was neutralized with Amberlite IR-120 
and filtered. Et3N (0.3 mL) was added and the reaction mixture was purified by 
Sephadex LH-20 chromatography (CH2Cl2-MeOH 1:1). The residue was converted into 
the sodium salt by elution from a column of Dowex 50WX4-Na+ with MeOH-H2O 9:1 
to give 18 (8 mg, 64%). TLC (EtOAc:MeOH:H2O 20:5:3) Rf 0.25; 1H-NMR (500 MHz, 
MeOD):  7.45 (m, 4H, Ar), 7.27-7.17 (m, 16H, Ar), 7.03 (m, 2H, Ar), 6.81 (m, 2H, 
Ar), 5.04 (m, 2H, CH2(Bn)), 4.80 (d, J1,2 = 7.9 Hz, 1H, H-1A), 4.74 (2d, Jgem = 10.6 Hz, 
2H, CH2(Bn)), 4.68 (d, J1,2 = 8.6 Hz, 1H, H-1B), 4.62 (d, J1,2 = 8.6 Hz, 1H, H-1D), 4.50 
(2d, Jgem = 10.6 Hz, 2H, CH2(Bn)), 4.43 (d, J1,2 = 7.2 Hz, 1H, H-1C), 4.34 (2d, Jgem = 
12.0 Hz, 2H, CH2(Bn)), 4.05 (pt, 1H, H-4A), 3.93 (pt, 1H, H-4C), 3.87 (dd, J2,3= 10.1 
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Hz, J1,2 = 8.6 Hz, 1H, H-2B), 3.84-3.72 (m, 7H, H-6B, H-6D, H-5A, H-5C and OCH3), 
3.67-3.51(m, 6H, H-6B, H-6D, H-2A, H-2D, H-3B and H-3A), 3.49-3.43 (m, 4H, H-4B, 
H-5B, H-2C and H-3C), 3.39-3.36 (m, 3H, H-3D, H-4D and H-5D), 2.06 (2s, 6H, 
NHCOCH3) ppm; 13C-NMR (125 MHz, MeOD) (selected data from HSQC 
experiment):  152.8-115.1 (Ar), 104.3 (C-1C), 103.1 (C-1A), 100.8 (C-1B and C-1D), 
85.2 (C-3B), 83.7 (C-3A), 83.3 (C-4B or C-5B or C-2C or C-3C), 79.7 (C-4A), 79.4 (C-
4C), 78.2 (C-5A or C-5C), 78.0 (C-3D or C-4D or C-5D), 77.5 (C-3D or C-4D or C-
5D), 76.9 (C-4B or C-5B or C-2C or C-3C), 76.9 (C-5A or C-5C), 75.2 (2xCH2(Bn)), 
74.5 (CH2(Bn)), 74.3 (CH2(Bn)), 73.9 (C-2A), 73.8 (C-4B or C-5B or C-2C or C-3C), 
72.1 (C-3D or C-4D or C-5D), 70.6 (C-6B and C-6D), 70.5 (C-4B or C-5B or C-2C or 
C-3C), 57.8 (C-2D), 56.2 (C-2B), 55.8 (OCH3), 23.1 (2xNHCOCH3); HR MS: m/z: 
calcd for C63H72N2O24: 620.2243; found: 620.2280 [M]2-.  
A solution of 18 (8.0 mg, 6.2 µmol, as sodium salt) in H2O/MeOH (4.5 mL/0.5 mL) was 
hydrogenated at 2 bar pressure  in the presence of Pd(OH)2 (17 mg). After 48h, the 
suspension was filtered over Celite and concentrated. The residue was purified by 
Sephadex G-10 chromatography (H2O-MeOH 9:1) to give 1 after lyophilisation (5.6 
mg, quantitative). 1H-NMR (500 MHz, D2O):  7.09 (m, 2H, Ar), 6.97 (m, 2H, Ar), 
4.99 (d, J1,2 = 7.9 Hz, 1H, H-1A), 4.57 (d, J1,2 = 8.4 Hz, 1H, H-1B), 4.52 (d, J1,2 = 8.3 
Hz, 1H, H-1D), 4.46 (d, J1,2 = 7.9 Hz, 1H, H-1C), 3.92 (m, 2H, H-6B and H-6D), 3.87-
3.65 (m, 13H, H-2B, H-4A, H-5A, H-6B, H-6D, OCH3, H-4C, H-5C, H-3B, H-2D and 
H-3A), 3.61-3.56 (m, 2H, H-2A and H-3C), 3.55-3.44 (m, 5H, H-4B, H-3D, H-4D, H-
5D and H-5B), 3.34 (pt, 1H, H-2C), 2.04 (s, 3H, NHCOCH3), 2.02 (s, 3H, NHCOCH3) 
ppm; 13C-NMR (125 MHz, D2O) (selected data from HSQC experiment):  118.0, 114.9 
(Ar), 103.0 (C-1C), 101.2 (C-1A), 100.6 (C-1D), 100.4 (C-1B), 82.4 (C-3B or C-4C or 
C-5C), 79.8 (C-4A or C-5A), 79.6 (C-3B or C-4C or C-5C), 76.5 (C-4A or C-5A), 76.1 
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(C-3B or C-4C or C-5C), 75.4 (C-4B or C-5B or C-3D or C-4D or C-5D), 75.2 (C-4B or 
C-5B or C-3D or C-4D or C-5D), 73.8 (C-4B or C-5B or C-3D or C-4D or C-5D), 73.5 
(C-3C), 73.6 (C-3A), 72.5 (C-2A), 72.4 (C-2C), 69.4 (C-4B or C-5B or C-3D or C-4D 
or C-5D), 68.4 (C-4B or C-5B or C-3D or C-4D or C-5D), 60.4 (C-6B and C-6D), 55.6 
(OCH3), 55.2 (C-2D), 54.2 (C-2B), 22.5 (2xNHCOCH3); HR MS: m/z: calcd for 
C35H48N2O24: 440.1304; found: 440.1323 [M]2-.  
4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-Heptadecafluoroundecyl 
(4-methoxyphenyl 2-O-benzoyl-3-O-benzyl-β-D-glucopyranoside) uronate (20): 
TEMPO (0.39 mL of a 0.016 M solution in CH2Cl2), Bu4NBr (0.13 mL of a 0.08 M 
solution in CH2Cl2) and KBr (40 µL of a 0.5 M solution in H2O) were added dropwise 
at 0ºC to a solution of diol 19 (100 mg, 0.21 mmol) in CH2Cl2 (2.1 mL). A solution of 
Ca(ClO)2 (74 mg, 0.52 mmol) and NaHCO3 (75 mg, 0.9 mmol) in H2O (2.0 mL) was 
then added dropwise at 0ºC. After stirring for 45 min at 0ºC, the reaction was quenched 
by adding Na2SO3 (1.3 mL of a 0.8 M solution in H2O). After stirring for 15 min at 0ºC, 
the reaction mixture was diluted with additional CH2Cl2 and H2O, and the organic layer 
was then separated, washed with a solution of Na2SO3 (0.8 M) and brine, dried 
(MgSO4), filtered and concentrated. The residue was dissolved in DMF (3 mL) and 
4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecyl iodide (245 mg, 0.42 
mmol) was added. The mixture was stirred for 3 h at 60 ºC, diluted with EtOAc, washed 
with H2O, dried (MgSO4) and concentrated. Flash chromatography (toluene/EtOAc, 
12:1) gave 20 (110 mg, 55%). TLC (6:1 toluene/EtOAc) Rf 0.39; [α] 20D  –1.7º (c 1.0, 
CH2Cl2); 1H-NMR (300 MHz, CDCl3): δ 8.03 (m, 2H, Ar), 7.60 (m, 1H, Ar), 7.46 (m, 
2H, Ar), 7.19 (m, 5H, Ar), 6.89 (m, 2H, Ar), 6.73 (m, 2H, Ar), 5.49 (dd, J 1,2 = 7.6 Hz, J 
2,3 = 9.2 Hz, 1H, H-2), 5.02 (d, 1H, J 1,2 = 7.6 Hz, H-1), 4.78 (s, 2H, CH2(Bn)), 4.30 (m, 
2H, CH2(CH2)2C8F17), 4.17 (pt, 1H, H-4), 4.00 (d, J 4,5 = 9.7 Hz, 1H, H-5), 3.79 (pt, 1H, 
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H-3), 3.72 (s, 3H, OCH3), 2.29-1.97 (m, 4H, CH2(CH2)2C8F17) ppm; 13C-NMR (75 
MHz, CDCl3): δ 169.0, 165.3 (CO), 156.0-114.5 (Ar), 101.5 (C-1), 80.8 (C-3), 74.7 
(CH2(Bn), 74.4 (C-5), 73.1 (C-2), 71.8 (C-4), 64.4 (CH2(CH2)2C8F17), 55.5 (OCH3), 
28.1-20.0 (CH2(CH2)2C8F17); HR MS: m/z: calcd for C38H31F17NaO9: 977.1594; found: 
977.1627 [M+Na]+.  
4-Methoxyphenyl O-(benzyl 2-O-benzoyl-3-O-benzyl-4-O-levulinoyl-β-D-
glucopyranosyluronate)-(1→3)-O-(4-O-acetyl-6-O-benzyl-2-deoxy-2-
trichloroacetamido-β-D-glucopyranosyl)-(1→4)- 
4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-heptadecafluoroundecyl 2-O-benzoyl-3-O-
benzyl-β-D-glucopyranosiduronate (23): Donor 4 (62 mg, 0.09 mmol) and aceptor 20 
(65 mg, 0.07 mmol) were coevaporated with toluene and dissolved in dry CH2Cl2 (1 
mL) in the presence of activated 4Å MS. The reaction mixture was stirred, under an 
argon atmosphere, for 10 min at 0ºC and TMSOTf (3.2 µL, 18 µmol) was added. After 
stirring for 15 min at 0ºC, the reaction mixture was quenched with triethylamine, 
filtered, and then concentrated under reduced pressure. The crude product was purified 
using a fluorous solid-phase extraction (FSPE) cartridge. Nonfluorous compounds were 
eluted with 80:20 MeOH/water and the desired fluorous product was eluted by 100% 
MeOH. This MeOH fraction was concentrated and submitted to a second coupling cycle 
with additional donor 4 (16 mg, 0.022 mmol). The mixture was dissolved in dry CH2Cl2 
(1 mL) in the presence of activated 4Å MS and then stirred, under an argon atmosphere, 
for 10 min at 0 ºC. TMSOTf (0.82 µL, 4.5 µmol) was added. After stirring for 15 min at 
0ºC, the reaction mixture was neutralized with Et3N, filtered, and concentrated to 
dryness. The reaction mixture was purified by using a FSPE column as described above. 
The methanolic fraction was concentrated to give disaccharide 21 and a small amount of 
unreacted aceptor 20. Data for disaccharide 21: TLC (6:1 toluene/EtOAc) Rf 0.29; 
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Selected 1H NMR data (500 MHz, CDCl3): δ 5.41 (dd, 1H, H-2A), 5.18 (pt, 1H, H-3B), 
5.12 (pt, 1H, H-4B), 5.09 (d, 1H, H-1A), 5.03 (d, 1H, H-1B), 4.93, 4.67 (2d, 2H, 
CH2(Bn)), 4.34-4.27 (m, 3H, H-4A and CH2(Bn)), 4.18-4.07 (m, 4H, H-2B, H-5A and 
COOCH2), 3.88 (pt, 1H, H-3A), 3.71 (s, 3H, OCH3), 3.67 (m, 1H, H-5B), 3.51 (dd, 1H, 
H6B), 3.35 (dd, 1H, H6B), 2.76-2-43 (m, 4H, OCO(CH2)2) ppm; ESI MS: m/z: calcd for 
C60H55Cl3F17NNaO17: 1514.1; found: 1514.4 [M+Na]+. 
The residue containing 21 (75 mg) was dissolved in CH2Cl2 (1.5 mL) and hydrazine 
monohydrate (67 µL of a 1 M solution in Py/AcOH 3:2) was added. After stirring at 
room temperature for 2 h, the reaction mixture was quenched with acetone. The mixture 
was concentrated in vacuo, coevaporated with toluene and loaded on a FSPE column. 
The methanolic fraction contained acceptor 22. Selected 1H NMR data for 22 (500 
MHz, CDCl3): δ 5.43 (dd, 1H, H-2A), 5.09 (d, 1H, H-1A), 4.95 (m, 3H, H-1B, H-4B 
and CH2(Bn)), 4.66 (d, 1H, CH2(Bn)), 4.30-4.11 (m, 6H, H-4A, H-5A, COOCH2 and 
CH2(Bn)), 3.87 (m, 2H, H-3A and H-2B), 3.79 (m, 1H, H-3B), 3.71 (s, 3H, OCH3), 3.61 
(m, 1H, H-5B), 3.53 (dd, 1H, H-6B), 3.37 (dd, 1H, H-6B) ppm; ESI MS: m/z: calcd for 
C55H49Cl3F17NO15: 1416.2; found: 1416.2 [M+Na]+. 
The residue containing acceptor 22 (70 mg) and donor 3 (45 mg, 0.062 mmol) were 
coevaporated with toluene and dissolved in dry CH2Cl2 (1 mL) in the presence of 
activated 4Å MS. The reaction mixture was stirred, under an argon atmosphere, for 10 
min at r.t. and TMSOTf (1.1 µL, 6.2 µmol) was added. After stirring for 15 min, the 
reaction mixture was neutralized with Et3N, filtered, and concentrated to dryness. The 
reaction mixture was loaded on a fluorous solid phase extraction (FSPE) column. 
Nonfluorous compounds were eluted with 80% MeOH/water and the desired product 
was eluted by 100% MeOH. This MeOH fraction was concentrated and submitted to a 
second coupling cycle. The methanolic residue and donor 3 (45 mg, 0.062 mmol) were 
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dissolved in dry CH2Cl2 (1 mL) in the presence of activated 4Å MS. The reaction 
mixture was stirred, under an argon atmosphere, for 10 min at r.t. and TMSOTf (1.1 µL, 
6.2 µmol) was added. After stirring for 15 min at r.t., the reaction mixture was 
neutralized with Et3N, filtered, and concentrated to dryness. The crude mixture was 
loaded on a FSPE column. The methanolic eluent was further purified by PLC on silica 
gel (6:1 toluene/EtOAc) to give trisaccharide 23 (16 mg, 12% from 20). TLC (4:1 
toluene/EtOAc) Rf 0.32; [α] 20D  +6.8º (c 1.0, CH2Cl2); 1H-NMR (400 MHz, CDCl3):  
8.03 (m, 2H, Ar), 7.94 (m, 2H, Ar), 7.56 (m, 2H, Ar), 7.46-7.06 (m, 25H, Ar and NH), 
6.86 (m, 2H, Ar), 6.72 (m, 2H, Ar), 5.40 (dd, 1H, J1,2 = 6.5 Hz, J2,3 = 8.1 Hz, H-2A), 
5.27-5-22 (m, 2H, H-2C and H-4C), 5.16-5.13 (m, 2H, H-1B and CH2(Bn)), 5.10-5.06 
(m, 2H, H-1A and CH2(Bn)), 4.97 (pt, 1H, H-4B), 4.85 (d, 1H, J1,2 = 7.5 Hz, H-1C), 
4.76 (d, 1H, Jgem = 11.8 Hz, CH2(Bn)), 4.60-4.52 (m, 3H, CH2(Bn)), 4.44-4.29 (m, 4H, 
H-4A, H-3B and CH2(Bn)), 4.16 (m, 1H, CH2(CH2)2C8F17), 4.09 (m, 1H, 
CH2(CH2)2C8F17), 4.05 (d, 1H, J4,5 = 8.1 Hz, H-5A), 3.99 (d, 1H, J4,5 = 10.0 Hz, H-5C), 
3.83 (pt, 1H, H-3A), 3.76 (pt, 1H, H-3C), 3.71 (s, 3H, OCH3), 3.62 (m, 1H, H-5B), 3.49 
(m, 2H, H-2B and H-6aB), 3.31 (dd, 1H, J5,6b= 5.4 Hz, J6a,6b= 10.7 Hz, H-6bB), 2.54-
2.28 (m, 4H, OCO(CH2)2), 2.21-2.02 (m, 7H, CH2 (CH2)2C8F17 and COCH3), 1.71 
(COCH3) ppm; 13C-NMR (100 MHz, CDCl3):  205.9, 171.3, 169.8, 168.6, 167.1, 
165.1 164.6, 161.5 (CO), 155.6-114.4 (Ar), 100.5 (C-1A), 98.6 (C-1C), 98.4 (C-1B), 
92.6 (CCl3), 79.1 (C-3A or C-3C), 78.9 (C-3A or C-3C), 76.3 (C-4A or C-3B), 75.7 (C-
4A or C-3B), 74.6, 74.3, 74.0, 73.8, 73.6, 73.1, 72.6, 72.5, 71.1 (3 x CH2(Bn), C-5A, C-
5B, C-2A, C-4C, C-5C and C-2C), 69.2 (C-6B), 68.2 (C-4B), 68.0 (CH2(Bn)), 64.5 
(CH2(CH2)2C8F17), 58.8 (C-2B), 55.4 (OCH3), 37.5 (OCO(CH2)2), 29.7 (COCH3), 27.6 
(OCO(CH2)2),  28.0-27.2 (CH2(CH2)2C8F17), 20.4 (COCH3); HR MS: m/z: calcd for 
C87H79Cl3F17NNaO24: 1972.3684; found: 1972.3987 [M+Na]+. 
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